CN1176795A - Traditional Chinese medicine- - Google Patents
Traditional Chinese medicine- Download PDFInfo
- Publication number
- CN1176795A CN1176795A CN96109694A CN96109694A CN1176795A CN 1176795 A CN1176795 A CN 1176795A CN 96109694 A CN96109694 A CN 96109694A CN 96109694 A CN96109694 A CN 96109694A CN 1176795 A CN1176795 A CN 1176795A
- Authority
- CN
- China
- Prior art keywords
- radix
- cancer
- chinese medicine
- rhizoma
- traditional chinese
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
A traditional Chinese meidicine for treating cancer is composed of Radix Astragali seu Hedysari,Ginseng, Cornu Cervi, Herba Hedyotis Diffusae, Plastrum Testudinis, Radix Notoginseng, Rhizoma Zedozariae, Radix Arnebiae seu Lithowpermi, Rhizoma Sparganii, Concha Ostreae, sea weed, Sal Ammoniaci etc. The present invention can influence the patient's cancer apparently.
Description
The present invention relates to a kind of Chinese medicine that is used for the treatment of cancer.
Cancer is very high commonly encountered diseases of world today's M ﹠ M and difficult disease, still lacks the specific treatment means so far.Chemotherapy and radiation method commonly used has fettered its life-time service and has produced a desired effect because of it inevitably can cause the numerous bad reflection based on hemopoietic system and immune system infringement.More people likes adopting Chinese medicine to treat or auxiliary for treating cancer, and the most curative effect of various Chinese medicines of existing treatment cancer is obvious inadequately, the employing rare Chinese medicine that takes effect slow or more, and expenses for medicine is higher.
Purpose of the present invention overcomes above-mentioned the deficiencies in the prior art exactly, and the Chinese medicine of the treatment cancer that a kind of medicine source is extensive, cost is low and evident in efficacy is provided.
In order to achieve the above object, the present invention adopts the medicine of resolving phlegm and softening hard masses and blood circulation promoting and blood stasis dispelling, is beneficial to dwindling and eliminating of tumor body; Adopt the antipyretic and antidotal type medicine to help dispeling of poison; The medicine of reinforcing spleen and kidney, benefiting QI and nourishing blood then helps the reflex of healthy energy, and positive what is called is set upright with eliminating evil.In addition, Radix Ginseng contains the material of anticancer growth, and the growth of ehrlich carcinoma is had inhibitory action; Herba Hedyotidis Diffusae all has obvious inhibitory action to ehrlich carcinoma, yoshida sarcoma etc.; Rhizoma Curcumae has better curative effect to sarcoma, and QI invigorating such as the Radix Astragali, invigorate blood circulation, reduce phlegm, heat clearing away class medicine, have the cellular immunization of enhancing and humoral immune function mostly, improve the effect of organismic internal environment.The present invention adopts the Radix Astragali, Radix Ginseng, Cornu Cervi, Gekko Swinhonis, Scorpio, Herba Hedyotidis Diffusae, Carapax et Plastrum Testudinis, Radix Notoginseng, Rhizoma Curcumae, Radix Arnebiae (Radix Lithospermi), rhizoma sparganic, Concha Ostreae, Sargassum, Sal Ammoniacus to form, and has stronger hard masses softening and resolving, blood circulation promoting and blood stasis dispelling, strengthening vital QI to eliminate pathogenic factors, heat-clearing and toxic substances removing, invigorating the spleen and regulating the stomach function.
The present invention's prescription by part (part is unit of weight) is:
Huang Shi 10-15 part, Radix Ginseng 6-10 part, Cornu Cervi 1-2 part, Gekko Swinhonis 3-6 part, Scorpio 6-9 part, Herba Hedyotidis Diffusae 12-18 part, Carapax et Plastrum Testudinis 3-6 part, Radix Notoginseng 1-3 part, Rhizoma Curcumae 3-6 part, Radix Arnebiae (Radix Lithospermi) 15-20 part, rhizoma sparganic 6-9 part, Concha Ostreae 20-30 part, Sargassum 15-20 part, Sal Ammoniacus 0.3-0.6 part.
Preparation method of the present invention is to choose authentic medicinal herbs, divides for another method by " pharmacopeia " regulation and concocts, and is ground into fine powder, crosses 180 mesh sieves, promptly gets powder after the packing sterilization.The present invention also can make tincture or pill as required, and method for making gets final product routinely.
Instructions of taking is secondary every day, each 10 gram powder, and per stage is 12 days, and drug withdrawal was had a rest two days between two stages, and three phases is a course of treatment.Period in a medicine can be equipped with support and symptomatic treatments such as liquid, infection.
The patient treats three courses of treatment continuously, and after leaving hospital, follow up a case by regular visits to once every year.The criterion of observe the curative effect is: produce effects is a clinical symptom disappearance, and image check shows that the tumor body dwindles, and follows up a case by regular visits to alive.Effectively obviously improve for clinical symptoms, image check shows that the tumor body does not increase, and do not have to shift, and the state of an illness does not have and increases the weight of and worsen, and follows up a case by regular visits to the existence of lotus tumor after leaving hospital 1 year.Invalidly improve not obvious or only have slight improvement, image check to show that the tumor body enlarges or shifts for clinical symptoms, increase the weight of during the treatment, dead, use other therapies instead or leave hospital dead in back 1 year.
The present invention is through a large amount of clinical observations, and total effective rate reaches 95%, and obvious effective rate reaches 52.5%.Clinical observation shows, the present invention has good action to the cachexia of eliminating or improve the cancer patient (expendable sign), the original severe cachexia in treatment back has obviously and alleviates, in original, mild then can improve or disappear, illustrate that this medicine can obviously improve cancer patient's body constitution and life quality, have laid a good foundation for further treating.The present invention also can obviously influence patient's tumor body, has quite a few to dwindle, thereby can improve cancer patient's therapeutic effect greatly.
The better embodiment of the present invention is: Radix Astragali 15g, Radix Ginseng 10g, Cornu Cervi 1.5g, Gekko Swinhonis 6g, Scorpio 6g, Herba Hedyotidis Diffusae 15g, Carapax et Plastrum Testudinis 3g, Radix Notoginseng 1.5g, Rhizoma Curcumae 5g, Radix Arnebiae (Radix Lithospermi) 18g, rhizoma sparganic 9g, Concha Ostreae 25g, Sargassum 18g, Sal Ammoniacus 0.5g.Grind into powder and make powder, pack sterilization, every bag heavy 10 gram.
Medicine of the present invention source is extensive, cost is low, evident in efficacy, be mainly used in the treatment of digestive system, respiratory system, urinary system and gynecological cancer, other cancer is also had adjuvant treatment effect preferably.
Claims (1)
1. Chinese medicine for the treatment of cancer is characterized in that its prescription is (part be unit of weight):
Radix Astragali 10-15 part, Radix Ginseng 6-10 part, Cornu Cervi 1-2 part, Gekko Swinhonis 3-6 part, Scorpio 6-9 part, Herba Hedyotidis Diffusae 12-18 part, Carapax et Plastrum Testudinis 3-6 part, Radix Notoginseng 1-3 part, Rhizoma Curcumae 3-6 part, Radix Arnebiae (Radix Lithospermi) 15-20 part, 6～9 parts of rhizoma sparganic, Concha Ostreae 20-30 part, Sargassum 15-20 part, Sal Ammoniacus 0.3-0.6 part.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN96109694A CN1059575C (en) | 1996-09-18 | 1996-09-18 | Traditional Chinese medicine- |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN96109694A CN1059575C (en) | 1996-09-18 | 1996-09-18 | Traditional Chinese medicine- |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1176795A true CN1176795A (en) | 1998-03-25 |
| CN1059575C CN1059575C (en) | 2000-12-20 |
Family
ID=5120527
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN96109694A Expired - Fee Related CN1059575C (en) | 1996-09-18 | 1996-09-18 | Traditional Chinese medicine- |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1059575C (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1068523C (en) * | 1998-08-28 | 2001-07-18 | 周伟 | Medicine for treating cancer and its preparing technology |
| CN101264268B (en) * | 2008-05-05 | 2011-07-13 | 李安治 | Proprietary Chinese medicine for treating tumor |
-
1996
- 1996-09-18 CN CN96109694A patent/CN1059575C/en not_active Expired - Fee Related
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1068523C (en) * | 1998-08-28 | 2001-07-18 | 周伟 | Medicine for treating cancer and its preparing technology |
| CN101264268B (en) * | 2008-05-05 | 2011-07-13 | 李安治 | Proprietary Chinese medicine for treating tumor |
Also Published As
| Publication number | Publication date |
|---|---|
| CN1059575C (en) | 2000-12-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN100586468C (en) | Chinese medicine for treating hepatitis B | |
| CN1164308C (en) | Osteological Chinese medicine prepn. | |
| CN1562160A (en) | Composite medicine for treating hepatitis B complication | |
| CN101062372A (en) | Chinese herbal medicine preparation for dissolving hepatobiliary system calculi | |
| CN1589881A (en) | Chinese medicinal prescription for treating gastropathy | |
| CN1112836A (en) | Meicinal prepn. "Kexianling" for curing epilepsy | |
| CN101041043A (en) | Liver cancer treating traditional Chinese medicine | |
| CN101711848B (en) | Chinese medicinal composition capable of adjunctively treating tumour | |
| CN101695555B (en) | Medicament composition for treating prostatitis and prostatomegaly and preparation method thereof | |
| CN103638190B (en) | The Chinese medicine for the treatment of acute cholecystitis | |
| CN101543616B (en) | Traditional Chinese medicine composition for preventing and treating tumor and its preparation method | |
| CN105434972A (en) | Traditional Chinese medicine composition for treating breast hyperplasia | |
| CN1059575C (en) | Traditional Chinese medicine- | |
| CN1052889C (en) | Chinese proprietary for curing hepatitis | |
| CN104258305A (en) | Traditional Chinese medicine preparation for treating chronic liver and gall diseases | |
| CN104547736A (en) | Medicine for treating goiter | |
| CN103705846A (en) | Traditional Chinese medicine preparation for treating ovarian cyst | |
| CN103040990B (en) | Pharmaceutical composition for treating malignant tumors and preparation method thereof | |
| CN110638955A (en) | Chinese medicinal composition for treating arthralgia | |
| CN104825991A (en) | Traditional Chinese medicine preparation for alcoholism induced mental disorder, and preparation method thereof | |
| CN1907318A (en) | Use of ceylon houndstongue and pharmaceutical composition containing same | |
| CN1428158A (en) | Chinese medicine for curing gastropathy | |
| CN102872293A (en) | Traditional Chinese medicinal powder for treating rheumatism and rheumatoid disease | |
| CN101554461B (en) | Medicine for treating psoriasis and preparation method of capsule thereof | |
| CN1876062A (en) | Preparation method of traditional Chinese medicine for treating hepatitis B and liver cirrhosis and Chinese medicine prepared thereby |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C19 | Lapse of patent right due to non-payment of the annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |